drugset
drugset / Press release

D07001 (GemOral) Phase II/III clinical trial in humans for advanced bile duct cancer (Project No. INNO-GO-05) has been approved

2021-10-04 · InnoPharmax Inc. · original innopharmax.com ↗

D07001 · regulatory

D07001 (GemOral) Phase II/III clinical trial in humans for advanced bile duct cancer (Project No. INNO-GO-05) has been approved by Taiwan Food and Drug Administration (TFDA).

The release as fetched from its publisher. innopharmax.com ↗